在意大利某大型烧伤中心实施Nexobrid用于烧伤清创:患者结局的回顾性回顾
这项回顾性研究分析了意大利某大型烧伤中心2019年10月至2023年6月接受Nexobrid酶性清创的30例患者,10%无需进一步手术干预,但超过80%仍需额外手术干预,约10%死于全身并发症,作者认为Nexobrid是烧伤创面管理的工具而非确定性解决方案。
要点
- 30例接受Nexobrid治疗的患者中,10%无需进一步手术干预。
- 超过80%的患者仍需额外手术干预。
- 约10%的患者死于全身并发症。
核心结论
- Nexobrid在烧伤清创中既有潜在获益也有局限,仅使小部分患者免于进一步手术干预,多数患者仍需额外手术操作,应被视为烧伤创面管理的工具而非确定性解决方案。
- 研究结果与既往研究存在差异,作者建议未来开展随机对照试验、Nexobrid与传统清创方法的直接比较以及更大更多样化患者群体的研究。
研究设计与样本
- 回顾性研究,利用患者数据库识别2019年10月至2023年6月期间接受Nexobrid治疗的患者,共30例。
- 回顾性分析收集人口学信息、烧伤原因、操作细节和患者结局。
主要发现
- 30例接受Nexobrid治疗的患者中,10%无需进一步手术干预。
- 超过80%的患者仍需额外手术干预。
- 少数患者出现并发症,约10%的患者死于全身并发症。
临床怎么用
- 作者认为Nexobrid应被视为烧伤创面管理的工具而非确定性解决方案,其有效性因患者而异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This retrospective study examines the implementation of Nexobrid, an enzymatic debriding agent developed from bromelain, for burn debridement in a major Italian burn center. With previous research showing encouraging results for Nexobrid in terms of reducing the need for surgical intervention and faster eschar removal, the current study aims to add to the growing body of evidence regarding its potential benefits and limitations. The patient database was utilized to identify patients who received Nexobrid treatment between October 2019 and June 2023. A retrospective analysis was conducted to gather demographic information, burn causes, procedural details, and patient outcomes. Of the 30 patients treated with Nexobrid, 10% did not require further surgical intervention, showcasing Nexobrid's potential to improve patient outcomes. However, over 80% of patients still required additional surgical intervention, demonstrating that Nexobrid's effectiveness varies across patients and should be considered a tool rather than a definitive solution in burn wound management. A few patients developed complications, and about 10% of patients succumbed to systemic complications. The study results reveal both the potential benefits and limitations of using Nexobrid in burn debridement. While it successfully eliminated the need for further surgical intervention in a small percentage of patients, the majority still required additional surgical procedures. These findings not only highlight Nexobrid's role as a tool in burn wound management but also point toward the discrepancies with previous studies. The authors suggest future research should include randomized controlled trials, direct comparisons between Nexobrid and traditional debridement methods, and studies incorporating larger and more diverse patient groups.
引用
- Lombardo GAG, Ciancio F, Violini H, et al. Implementing Nexobrid for Burn Debridement in a Major Italian Burn Center: A Retrospective Review of Patient Outcomes. J Burn Care Res. 2024. PMID: 37897805. doi:10.1093/jbcr/irad171
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。